Source:http://linkedlifedata.com/resource/pubmed/id/17649597
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2007-6-26
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
K
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
2153-8387
|
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:pagination |
3
|
pubmed:dateRevised |
2011-2-17
|
pubmed:meshHeading |
pubmed-meshheading:17649597-Cardiomyopathies,
pubmed-meshheading:17649597-Clinical Trials, Phase I as Topic,
pubmed-meshheading:17649597-Humans,
pubmed-meshheading:17649597-Mesenchymal Stem Cell Transplantation,
pubmed-meshheading:17649597-Myoblasts,
pubmed-meshheading:17649597-Myocardial Infarction
|
pubmed:year |
2007
|
pubmed:articleTitle |
Treating heart disease with stem cells. Novel therapy holds promise for victims of heart attack and heart failure.
|
pubmed:publicationType |
Journal Article
|